Treatment of cervicogenic headache with application of multicomponent bioregulation drug
Introduction. According to the data of various authors Cervicogenic headache (CH) is met in 2.5 to 70% of population. Diagnostic criteria are described at The International classification of headache (3d revision). CH represents a heterogeneous group of headaches based on functional and organic chan...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Remedium Group LLC
2020-07-01
|
| Serija: | Медицинский совет |
| Teme: | |
| Online pristup: | https://www.med-sovet.pro/jour/article/view/5686 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
